# REDUCER Trial (TXA in Urethroplasty)

> **NCT07501884** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Amjad Alwaal, MD, MSc, FRCSC, FACS** · enrollment: 40 (estimated)

## Conditions studied

- Urethral Stricture
- Urethral Diseases

## Interventions

- **DRUG:** Tranexamic Acid
- **PROCEDURE:** Urethroplasty

## Key facts

- **NCT ID:** NCT07501884
- **Lead sponsor:** Amjad Alwaal, MD, MSc, FRCSC, FACS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07501884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07501884, "REDUCER Trial (TXA in Urethroplasty)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07501884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*